Does NATALIZUMAB Cause Lung neoplasm malignant? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Lung neoplasm malignant have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.2% of all adverse event reports for NATALIZUMAB.
108
Reports of Lung neoplasm malignant with NATALIZUMAB
0.2%
of all NATALIZUMAB reports
25
Deaths
35
Hospitalizations
How Dangerous Is Lung neoplasm malignant From NATALIZUMAB?
Of the 108 reports, 25 (23.1%) resulted in death, 35 (32.4%) required hospitalization, and 12 (11.1%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 108 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which NATALIZUMAB Alternatives Have Lower Lung neoplasm malignant Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK